Design an AI-enabled software as a medical device that offers cutting-edge capabilities and earns the trust of healthcare professionals, ultimately improving patient care.
Back to team page
Coleen Long
Director
With a background in clinical, academic, and consumer research, Coleen brings to every project unique, creative insights and an eye for detail. Our clients benefit from her passion for understanding the needs of special populations to develop tools that improve overall quality of life. Coleen has leveraged multiple methods and approaches to lead research across a wide range of industries, including medical technology, commercial products, entertainment, and mental health. Coleen has a BS in Clinical Psychology from the University of Illinois at Urbana-Champaign.



Bold facts
Learn more about

Something unique about you summed up in one sentence

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:

How long have you been in the UX field?

You cannot start the day without doing this...

Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Do you have a long-term personal or professional goal you'd like to share?
Read our team’s latest bold insights
Why UX people make great strategy consultants
Learn why UX researchers excel as strategy consultants through data-driven approaches that address critical decisions and adapt to new contexts.
Global UX, mastered: The UXalliance’s 20-year collaboration story
This year marks the 20th anniversary of the UXalliance. To celebrate this milestone, we sat down with Gavin, one of the five founding members, to discuss the organization’s history, guiding principles, and the benefits it brings to clients.
Human factors testing for OTC drugs and non-prescription medical devices
As the field of human factors continues to evolve, so must our approaches to testing and study design. While the FDA’s 2013 guidance laid the groundwork for study design and methodology, recent discussions and conference presentations have prompted a shift in how we approach OTC HF testing, leading to more comprehensive and realistic assessments of these products.